Behrens M Kathleen

Behrens M Kathleen is listed in filings as Director at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 14 public disclosures. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT), IGM Biosciences, Inc. (IGMS), and MiMedx Group, Inc. (MDXG). The current snapshot covers public activity from Jul 2, 2024 to Jun 5, 2026. Reported amounts are shown as $144.0K to $477.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.